Clinical trial
Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients
NCT06666998 is registered in ClinicalTrials.gov with Sichuan Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients
- Lead sponsor
- Sichuan Provincial People's Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 1, 2024
- Completion date
- November 1, 2026
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bacteria infection, bacterial resistance to antimicrobial, empirical antimicrobial therapy, eravacycline, pharmacokinetics